Friday, July 31, 2026

LegoChem expands options beyond early ADC licensing into late-stage clinical development

LegoChem Biosciences secures funding to advance ADC therapies into late-stage trials, enhancing strategic flexibility in biotech.

Is the U.S. Defense Department’s Stance on Anthropic’s AI a Risk?

The NSA uses Anthropic's Claude Mythos AI despite Pentagon supply chain concerns, highlighting a gap in security practices.

Seoul Downplays Kim Jong Un’s APEC Attendance, Casts Trump as Key to Reviving Talks

South Korea remains cautious about Kim Jong Un's APEC attendance, emphasizing Trump's role in potential U.S.-North Korea talks.

In Soo Jang

No posts to display

Top News

- Our Sponsors Ad -

Follow us